Table 1 General characteristics of the study population
Number of patients (%) | |
|---|---|
Histology | |
Ovarian cancer: | 31 (91.2) |
High grade serous adenocarcinoma | 26 (76.5) |
Low grade serous adenocarcinoma | 1 (2.9) |
Clear cell carcinoma | 1 (2.9) |
Borderline ovarian tumor | 2 (5.9) |
Endometrioid adenocarcinoma | 1 (2.9) |
Endometrial cancer | 3 (8.8) |
Endometrioid adenocarcinoma | 2 (5.9) |
Serous adenocarcinoma | 1 (2.9) |
FIGO stage | |
IB | 1 (2.9) |
IC | 1 (2.9) |
IIIB | 1 (2.9) |
IIIC | 13 (38.2) |
IV | 18 (52.9) |
First treatment | |
Cytoreductive surgery | 24 (70.6) |
Neoadjuvant chemotherapy | 10 (29.4) |
Ascites | 20 (58.8) |